| abstract |
The present invention relates to disorders characterized by elevated or dysregulated myostatin, disorders in which the interaction between follistatin and angiogenin can be used to enhance tissue function, neurological diseases or disorders , Methods of treating spinal injuries or diseases, bone diseases or disorders, diseases including glucose homeostasis, healing wounds, or providing neuroprotection, support of nervous system function, or managing metabolic diseases; Comprises administering an effective amount of angiogenin or angiogenin agonist. Also provided are nutraceuticals (functional foods) and compositions comprising angiogenin. |